Login
$HIT
$0.33 -$0.07 (16.61%) Live

$HIT SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Shrestha Sanjay K, Director

Received 2,500,000 shares as a grant or award

13 Nov 2026 Form 4: Qian LinLin, Director

Received 3,050,000 shares as a grant or award · Received 200,000 shares as a grant or award

13 Nov 2026 Form 4: Johnson Tim Donald, Director

Received 3,050,000 shares as a grant or award · Received 200,000 shares as a grant or award

13 Nov 2026 QUARTERLY REPORT
13 Nov 2026 8-K: Regulation FD Disclosure

An AI-Powered Marketplace Platform Helping Small- and Medium-Sized Businesses Access Better Self-Funded Health Plans

13 Nov 2026 8-K: Regulation FD Disclosure

Good afternoon, ladies and gentlemen, and welcome to Health In Tech’s Third Quarter 2026 Earnings Conference Call. All participants are currently in listen-only mode. After the prepared remarks, we will open the call for questions. As a ...

13 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Contracted Revenue of $32.7 Million for the First Nine Months of 2026 Pipeline Revenue of $156.4 Million as of October 30, 2026 Distribution Partners Grew 15.9% Year Over Year

12 Nov 2026 8-K: Submission of Matters to a Vote of Security Holders

On November 10, 2026, Health In Tech, Inc. (the “Company”) (Nasdaq: HIT) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). For more information on the proposals, which are described below, please refer to the Company’s...

06 Nov 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

As previously disclosed, on August 12, 2026, Health In Tech, Inc. (the “Company”) entered into a Standby Equity Purchase Agreement (the “SEPA”) and a related Registration Rights Agreement. On September 4, 2026, the Company satisfied the ...

05 Nov 2026 Form 4: Hasan Zain Syed, Chief Growth Officer

Sold 1,667 shares ($917)

28 Oct 2026 DEFINITIVE ADDITIONAL MATERIALS
26 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Health In Tech Appoints Sanjay Shrestha as Chief Executive Officer to Lead Next Phase of Growth and Strategic Expansion

22 Oct 2026 Form 4: Shrestha Sanjay K, Director

Received 5,000,000 shares as a grant or award · Received 500,000 shares as a grant or award

22 Oct 2026 Form 3: Shrestha Sanjay K, Director

Holds 101,200 shares of Class A Common Stock

19 Oct 2026 Form 4: Johnson Tim Donald, Director

Gave up 119,728 shares to cover exercise price or tax ($75.4K)

19 Oct 2026 Form 4: Hasan Zain Syed, Chief Growth Officer

Gave up 6,756 shares to cover exercise price or tax ($4.26K) · Sold 3,333 shares ($2.07K)

19 Oct 2026 Form 4: Qian LinLin, Director

Gave up 47,516 shares to cover exercise price or tax ($29.9K)

19 Oct 2026 PROSPECTUS
16 Oct 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

On October 14, 2026, Health In Tech, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Nasdaq Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the resignat...

15 Oct 2026 EFFECT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support